SCHEMBL16148241

SCHEMBL16148241

O=C(c1ccccc1)C(F)(F)c1ccc2ncccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PABPC1 P11940 1/20 0.56
▸ CYP3A4 P08684 1/20 0.50
▸ NPC1 O15118 4/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ALOX15 P16050 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ PLK1 P53350 1/20 0.46
▸ POLB P06746 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MET P08581 3/20 0.44
▸ DOT1L Q8TEK3 1/20 0.44
▸ BCAT1 P54687 1/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ TRPM8 Q7Z2W7 1/20 0.43
▸ MCL1 Q07820 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16158204 0.89 PABPC1 (0.46) PABPC1CYP3A4NPC1RAB9AALDH1A1
SCHEMBL30606842 0.86 PABPC1 (0.53) PABPC1CYP3A4NPC1RAB9AALDH1A1
SCHEMBL2698205 0.85 PABPC1 (0.50) PABPC1CYP3A4NPC1RAB9AALDH1A1
SCHEMBL16147295 0.83 MGAM (0.54) NPC1RAB9AALDH1A1SMN1; SMN2LMNA
SCHEMBL9924303 0.82 HTT (0.50) PABPC1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL30421806 0.81 NPC1 (0.48) PABPC1CYP3A4NPC1RAB9AALDH1A1
SCHEMBL9910478 0.81 NPC1 (0.48) PABPC1CYP3A4NPC1RAB9AALDH1A1
SCHEMBL16147513 0.81 PTPN1 (0.53) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL1696435 0.80 NPC1 (0.47) PABPC1CYP3A4NPC1RAB9AALDH1A1
Hydrochloric Acid SCHEMBL2698455 0.80 NPC1 (0.47) PABPC1CYP3A4NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9598340-B2 Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-21 — — US disclosed
US-9598340-B2 Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-21 — — US disclosed
US-9598340-B2 Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-21 — — US disclosed
US-20160052854-A1 METAL-CATALYZED COUPLING OF ARYL AND VINYL HALIDES WITH ALPHA, ALPHA-DIFLUOROCARBONYL COMPOUNDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-02-25 — — US disclosed
WO-2014165861-A1 METAL-CATALYZED COUPLING OF ARYL AND VINYL HALIDES WITH ALPHA, ALPHA-DIFLUOROCARBONYL COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-10-09 — — WO disclosed
WO-2014165861-A1 METAL-CATALYZED COUPLING OF ARYL AND VINYL HALIDES WITH ALPHA, ALPHA-DIFLUOROCARBONYL COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-10-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160052854-A1 METAL-CATALYZED COUPLING OF ARYL AND VINYL HALIDES WITH ALPHA, ALPHA-DIFLUOROCARBONYL COMPOUNDS SOD1, HACL2, VHL PABPC1 4436/4885CYP3A4 238/4885NPC1 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback